|
|
||||||||
Merck Institute for Therapeutic Research1,2,, Rahway, NJ 07065
Abstract
An 8-wk growth trial was conducted to assess the effects of continuous infusion of thyrotropin-releasing hormone (TRH) and an active TRH analog <Aad-His-Pro-NH2 (the <Aad is L-pyro-
-aminoadipic acid) on growth trial performance, carcass composition and hormone profiles of growing lambs. Both drugs were infused at 600 βg*lamb–1 *d–1 with 16 lambs/treatment. Both TRH and <Aad-His-Pro-NH2 decreased average daily gain (ADG; P<.Q1) and increased feed conversion (FC; P<.01) compared with saline infused controls. Average daily feed intake was not altered. Carcasses of lambs given TRH or <Aad-His-Pro-NH2 contained fewer kilograms of moisture (P<.05) and appeared to contain fewer kilograms of protein. Thyrotropin-releasing hormone and <Aad-His-Pro-NH2 increased thyroid gland weights (P<.05), but pituitary gland weights were not different. Plasma thyrotropin (TSH) concentrations were increased by both drugs compared with control lambs, peaking at 4 to 7 d after initiating infusion. However, by 14 d, TSH concentrations returned to control levels. Triiodothyronine (T3) and thyroxine (T4) were elevated by both drugs over the entire 8-wk trial, with peak levels reached at 10 d and maintained for the duration of the study. Both TRH and <Aad-His-Pro-NH2 increased prolactin over the entire period. Growth hormone levels were not altered by either drug. The effects of <Aad-His-Pro-NH2 infusion on growth trial performance, carcass composition and hormone profiles of growing lambs were very similar to TRH. The negative effects of TRH and <Aad-His-Pro-NH2 infusion on ADG, FC and carcass protein appear to be the result of elevated T3 and T4 levels.
1 Dept. of Anim. Nutr. and Physiol.
2 The authors express their appreciation to Paul Duquette and Eric Rickes for their technical assistance and to Dr. Martin Hichens for preparing 125I-labeled hormones.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |